Neuron state shapes the genetics of brain disease
Brain cells don’t always behave the same way.
Scientists have long known that certain gene variants raise the risk of brain disorders. But which cells activate those variants, and when, has been harder to pin down. A new study in Science combined two measurement methods simultaneously at the level of individual cells (single-cell multi-omics) to investigate this. Researchers first activated neurons and then measured how genetic activity shifted in response.
Activation state determines genetic risk expression
The findings showed that genetic risk factors for brain disorders were more pronounced in activated neurons than in resting ones. In other words, the state a cell is in partly determines whether a risk variant actually has an effect. This is relevant for conditions such as Alzheimer’s disease, schizophrenia, and depression, where neural activity plays a central role. This is what the researchers report in their Science publication.
Combining gene expression and chromatin accessibility in a single measurement per cell (single-cell multi-omics) yields a more precise picture than earlier methods. Previous research often examined cells at rest, potentially missing risk genes that are only active when neurons fire.
What this means for longevity research
Cognitive decline in older age is linked to changes in how neurons respond to stimulation. If genetic risk factors are most active in stimulated cells, an important question follows: do those factors become more or less active as neurons age? This study does not answer that directly. But it establishes a methodological foundation on which such questions can be built.
The study does not make causal claims about how brain diseases arise. It describes genetic associations in a specific cellular context. Further research will need to determine how far the findings generalise to human brain tissue.
Search terms to explore further: single-cell multi-omics neuron activation, genetic risk brain disorders cell context, neuropsychiatric gene expression